PROFOUND MEDICAL CORP. Current Income Tax Expense (Benefit)
PROFOUND MEDICAL CORP. (PROF) reported Current Income Tax Expense (Benefit) of $68.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-08-06
- PROFOUND MEDICAL CORP. current income tax expense (benefit) for the quarter ending 2026-06-30 was $68.00K, a 12.82% decline year-over-year.
- PROFOUND MEDICAL CORP. current income tax expense (benefit) for the quarter ending 2026-03-31 was $27.00K, a 34.15% decline year-over-year.
- PROFOUND MEDICAL CORP. current income tax expense (benefit) for the quarter ending 2025-12-31 was $12.00K.
- PROFOUND MEDICAL CORP. current income tax expense (benefit) for the quarter ending 2025-09-30 was $100.00K, a 43.50% decline year-over-year.
- PROFOUND MEDICAL CORP. current income tax expense (benefit) for fiscal 2025 was $231.00K, a 60.42% increase from fiscal 2024.
- PROFOUND MEDICAL CORP. current income tax expense (benefit) for fiscal 2024 was $144.00K.
- PROFOUND MEDICAL CORP. current income tax expense (benefit) for fiscal 2023 was -$187.00K.
| Period end | Current Income Tax Expense (Benefit) 3 month | Current Income Tax Expense (Benefit) 6 month | Current Income Tax Expense (Benefit) 9 month | Current Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $68.00K 10-Q · filed 2026-08-06 | $95.00K 10-Q · filed 2026-08-06 | $107.00K derived: sum of 3 quarters · filed 2026-08-06 | $207.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $27.00K 10-Q · filed 2026-05-07 | $39.00K derived: sum of 2 quarters · filed 2026-05-07 | $139.00K derived: sum of 3 quarters · filed 2026-05-07 | $217.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $112.00K derived: sum of 2 quarters · filed 2026-03-05 | $190.00K derived: sum of 3 quarters · filed 2026-08-06 | $231.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-13 | $178.00K derived: sum of 2 quarters · filed 2026-08-06 | $219.00K 10-Q · filed 2025-11-13 | $127.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $78.00K 10-Q · filed 2026-08-06 | $119.00K 10-Q · filed 2026-08-06 | $27.00K derived: sum of 3 quarters · filed 2026-08-06 | $204.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $41.00K 10-Q · filed 2026-05-07 | -$51.00K derived: sum of 2 quarters · filed 2026-05-07 | $126.00K derived: sum of 3 quarters · filed 2026-05-07 | $145.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $85.00K derived: sum of 2 quarters · filed 2026-03-05 | $104.00K derived: sum of 3 quarters · filed 2026-03-05 | $144.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $177.00K 10-Q · filed 2025-11-13 | $196.00K derived: sum of 2 quarters · filed 2025-11-13 | $236.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $19.00K 10-Q · filed 2025-08-14 | $59.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $40.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$187.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |